Presentation
We invite you to learn more about:
- Diagnosis and current treatment options for hairy cell leukemia (HCL)
- Clinical trials and emerging therapies for HCL treatment
- The importance of open communication with the healthcare team
Michael Grever, MD
Professor Emeritus, Internal Medicine/Hematology
The Ohio State University
Columbus, OH
For any questions or comments about this program, please email [email protected].
Program Support
Support for this program provided by AstraZeneca and The Leukemia & Lymphoma Society.